Screening for Avoidant/Restrictive Food Intake Disorder Symptoms Among Autistic Adults: Measurement Invariance With a Comparison General Sample
Autism Research · 2025
DOI: 10.1002/aur.70039 ↗At a glance
Vergleichsstudie in Autism Research, 2025. Written by Courtney E Breiner and 3 co-authors. Institution: New York State Psychiatric Institute, Columbia University Irving Medical Center, New York, New York, USA. Major MEDLINE topics: Avoidant Restrictive Food Intake Disorder, Autistic Disorder, Mass Screening. Cited 5 times so far (Crossref); 64 references. The full text is freely available in PubMed Central. Funded by: NIMH NIH HHS, The George Washington University, The University of South Alabama.
Abstract (original language)
Research suggests a higher prevalence of avoidant/restrictive food intake disorder (ARFID) in autistic people across the lifespan compared to the general population. However, ARFID symptoms in autistic people may be misattributed to core autistic traits and gastrointestinal symptoms that often co‐occur with autism. This diagnostic overshadowing could lead to the under‐recognition and under‐treatment of modifiable symptoms of psychopathology in autistic people. Validating ARFID symptom measures in this population is essential to screening for ARFID and tracking treatment outcomes in this population. Multigroup confirmatory factor analysis was used to evaluate the equivalence of the factor structure, factor loadings, and item intercepts of the Nine‐Item ARFID Screen (NIAS) between a sample of autistic adults ( n = 248) who self‐disclosed their diagnosis and a comparison general sample ( n = 398). There was support for strong measurement invariance (configural, metric, and scalar) on the NIAS. Autistic adults scored significantly higher on each of the three subscales: selective eating ( d = 0.54), appetite impairment ( d = 0.27), and fear‐driven avoidance of eating ( d = 0.37). The NIAS is a valid instrument for measuring ARFID symptomatology in autistic adults. Autistic adults experience elevated symptomatology across all three ARFID eating restrictions. Future research should address whether evidence‐based ARFID treatments are efficacious for autistic adults or need to be modified.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- New York State Psychiatric Institute, Columbia University Irving Medical Center, New York, New York, USA.
- Department of Psychology, George Mason University, Fairfax, Virginia, USA.
- Department of Speech, Language, and Hearing Sciences, The George Washington University, Washington, DC, USA.
- Research Center, Rogers Behavioral Health, Oconomowoc, Wisconsin, USA.
ORCID profiles: Courtney E Breiner, Goldie A McQuaid
Funding
- NIMH NIH HHS
- The George Washington University
- The University of South Alabama
- National Institute of Mental Health
- University of South Alabama
- George Washington University
Cite
APA
Breiner, C. E., McQuaid, G. A., Wallace, G. L., & Zickgraf, H. F. (2025). Screening for Avoidant/Restrictive Food Intake Disorder Symptoms Among Autistic Adults: Measurement Invariance With a Comparison General Sample. Autism Research. https://doi.org/10.1002/aur.70039
Vancouver
Breiner CE, McQuaid GA, Wallace GL, Zickgraf HF. Screening for Avoidant/Restrictive Food Intake Disorder Symptoms Among Autistic Adults: Measurement Invariance With a Comparison General Sample. Autism Research. 2025. doi:10.1002/aur.70039
BibTeX
@article{Breiner2025,
author = {Breiner, Courtney E and McQuaid, Goldie A and Wallace, Gregory L and Zickgraf, Hana F},
title = {Screening for Avoidant/Restrictive Food Intake Disorder Symptoms Among Autistic Adults: Measurement Invariance With a Comparison General Sample},
journal = {Autism Research},
year = {2025},
doi = {10.1002/aur.70039}
}
EUVIMED